Effect of Tarantula cubensis alcohol extract and Capecitabin combine in Colorectal Cancer rats

Effect of Tarantula cubensis alcohol extract and Capecitabin combine in Colorectal Cancer rats

Colon cancer (CRC) is one of the most common types of cancer in the world. In this study, the effects of Tarantula cubensis alcoholic extract (TCAE) and the Capecitabine in CRC were investigated. Wistar albino rats were divided into eight groups with 12 animals in each group: untreated healthy and...

Full description

Bibliographic Details
Main Authors:	Rahmi Canbar, Ozgur Ozdemir, Ahmet Levent Bas
Format:	Article
Language:	English
Published:	Universidad del Zulia 2023-06-01
Series:	Revista Científica
Subjects:	Azoxymethane Capecitabine colorectal cancer TCAE
Online Access:	https://produccioncientificaluz.org/index.php/cientifica/article/view/40304

Similar Items

Evaluation of Nanocarrier Targeted Drug Delivery of Capecitabine-PAMAM Dendrimer Complex in a Mice Colorectal Cancer Model
by: Fatemeh Nabavizadeh, et al.
Published: (2016-09-01)

Effect of Tarantula cubensis alcoholic extract and Nerium oleander distillate on cell proliferation markers in colon carcinogenesis
by: Ozgur Ozdemir, et al.
Published: (2022-08-01)

Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
by: Bradley Ashley Gue Ong, et al.
Published: (2022-04-01)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01)

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients
by: Yu Lu, et al.
Published: (2020-08-01)

Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients
by: Sara Shamseldin, et al.
Published: (2023-10-01)

Comparison of Efficacy Between S-1 and Capecitabine/Fluorouracil on Advanced Colorectal Cancer: A Meta-analysis
by: ZHAO Rongchang, et al.
Published: (2019-12-01)

Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis
by: Hui‐Zhong Jiang, et al.
Published: (2023-01-01)

Visfatin and Resveratrol Differentially Regulate the Expression of Thymidylate Synthase to Control the Sensitivity of Human Colorectal Cancer Cells to Capecitabine Cytotoxicity
by: Kuen-Lin Wu, et al.
Published: (2021-12-01)

Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
by: Jia X, et al.
Published: (2023-03-01)

Gum arabic and red propolis protecteting colorectal preneoplastic lesions in a rat model of azoxymethane
by: Vanessa Nogueira Lages Braga, et al.
Published: (2019-02-01)

Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer
by: Yasmin Cura, et al.
Published: (2023-12-01)

Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database
by: Qiao Yu, et al.
Published: (2023-01-01)

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study
by: Xiu Liu, et al.
Published: (2022-07-01)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
by: Afshin Derakhshani, et al.
Published: (2021-05-01)

Amelioration of Capecitabine Toxicity in Albino Rats Using Chrysanthemum Extract
by: Jaklin L. Faheem, et al.
Published: (2024-01-01)

Amelioration of Capecitabine Toxicity in Albino Rats Using Chrysanthemum Extract
by: Jaklin L. Faheem, et al.
Published: (2024-01-01)

Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
by: Jinsong Su, et al.
Published: (2019-01-01)

A Case of Long Partial Response to Combination Therapy of Bevacizumab and Capecitabine for Liver Metastases of Rectal Cancer
by: Atsushi Kawasaki, et al.
Published: (2011-01-01)

Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine
by: Mahshid Mohammadian, et al.
Published: (2019-08-01)

Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer
by: Shirley James, et al.
Published: (2021-04-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review
by: Yasmin Cura, et al.
Published: (2023-03-01)

Investigation into the Potential Role of <i>Propionibacterium freudenreichii</i> in Prevention of Colorectal Cancer and Its Effects on the Diversity of Gut Microbiota in Rats
by: Ifeoma Julieth Dikeocha, et al.
Published: (2023-04-01)

Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022-05-01)

Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
by: Manuela Terranova-Barberio, et al.
Published: (2017-12-01)

Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest
by: Maciej Kabat, et al.
Published: (2024-02-01)

Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study
by: Dellas Kathrin, et al.
Published: (2012-06-01)

Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
by: Mahshid Mohammadian, et al.
Published: (2017-01-01)

Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
by: Yue Liu, et al.
Published: (2022-05-01)

Capecitabine-Related Fourth Nerve Palsy: A Case Report
by: Marco Rocco Pastore, et al.
Published: (2024-04-01)

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer
by: John H. Strickler, et al.
Published: (2019-11-01)

The effect of aerobic and resistance exercise on the progression of colorectal cancer in an animal model
by: Marcelo Barbosa Neves, et al.
Published: (2023-10-01)

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies
by: Neel D. Trivedi, et al.
Published: (2021-03-01)

Acute arterial thrombosis in a colon cancer patient after administration of oxaliplatin with capecitabine chemotherapy “case report”
by: Tala Alawabdeh, et al.
Published: (2022-06-01)

Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
by: Giovanni Brandi, et al.
Published: (2018-06-01)

A Rare Case on Capecitabine Induced Acquired Palmoplantar Keratoderma
by: Tsaqilah L, et al.
Published: (2023-12-01)

Comparison of 2 different mouse models of colorectal cancer and their application
by: FENG Jianhua, et al.
Published: (2024-01-01)

The Effect of Captopril Added to Standard Chemotherapy Regimen Containing Capecitabine in the Prevention of Hand and Foot Syndrome in Patients with Colorectal Cancer
by: Mahnaz Roayaei, et al.
Published: (2019-10-01)

Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine
by: Linda Tognetti, et al.
Published: (2015-04-01)